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Abstract                      
Introduction: Cell transplantation is one of the main strategies for spinal cord injury repair. 
As OECs of the olfactory mucosa can be obtained by simple biopsy in all individuals without 
affecting their smell sensation, OECs considered as a promising candidate for autologous 
transplantation in the nervous system injury, especially for spinal cord repair. Thereby in the 
current study OECs were cultured from olfactory mucosa of 7 days old rats' pups and their 
purity was examined by flow-cytometry after simultaneous double staining for p75 and 
GFAP markers.  
Materials and methods: 7 days old Wistar rats' pups were deeply anesthetized by ketamine / 
xylazine (60/6mg/Kg). Then the nasal cavity was opened sagittally and the olfactory mucosa 
was separated from posterior part of nasal septum and at last OECs were obtained from 
lamina properia of olfactory mucosa and were cultured. The cultured cells were 
simultaneously immunolabeled for p75 and GFAP markers and finally purity of cultured cells 
assessed by flow-cytometry. 
Results: cultured OECs demonstrated two different morphologies, a spindle shape Schwann-
like and an astrocyte-like OECs with flat sheet-like morphology. In addition, simultaneous 
immunolabeling for p75 and GFAP markers of OECs exhibited   OECs were positive for both 
markers at the same time. The flow-cytometry results  displayed that 87.9±2.4% of cells were 
p75/ GFAP double positive cells,1.05±0.4 only p75 positive and 5.8±1.5% were single 
positive for GFAP. 
Conclusion: Purity of cultured OECs in our study is probably more than 87.9% by flow- 
owing to p75+/S100+ and GFAP+/S100+ olfactory ensheathing cells were not counted. Thus 
the culture procedure of this study seems to be a good protocol for OECs purifying and cell 
therapy in CNS damages. 
Keywords: OECs, Cell therapy, Spinal cord injury, Flowcytometry 
Introduction 
Spinal cord injury (SCI) is a major cause 
of disability but there is no universally 
accepted treatment yet. Recently, cell 
transplantation, has become one of the 
most promising therapeutic approaches for 
SCI, and was strongly examined by 
numerous investigators. A number of 
different types of stem cells, neural 
progenitors, and glial cells have been 
examined via experimental researches, but 
several reasons including safety and 
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efficacy, have excluded them from clinical 
uses (1).  
Some animal studies have reported that 
transplantation of bone marrow stromal 
cells, neural progenitor cells or olfactory 
ensheathing cells (OECs) can promote 
functional improvement following SCI (2-
7). 
Olfactory ensheathing cells (OECs) are 
considered as a specialized population of 
glial cells of the primary olfactory system 
which are existed in both PNS and CNS 
(8, 9). 
They ensheath olfactory axons in the 
olfactory bulb (OB), the region of 
termination of the olfactory sensory axons 
in the CNS, as well as the olfactory 
mucosa of the nasal cavity(9), hence the 
olfactory system has unique properties 
which consists of both PNS and CNS 
tissue and it is known, for its capacity, to 
support neurogenesis throughout life (10). 
OECs have the unique property of 
enfolding olfactory axons along the whole 
axonal path from the olfactory mucosa to 
the outer layer of olfactory bulb and 
prevention of their exposures to inhibitory 
molecules (11). These non-myelinating 
glial cells play a role in guiding the axons 
that grow from the olfactory mucosa 
through the lamina propria to the OB. 
Therefore, they have properties of both 
astrocytes and Schwann cells (8, 12-14) 
owing to their ability to live within the 
CNS as well as axonal growth. So OECs 
have been suggested for cellular therapy in 
the nervous system, mainly for spinal cord 
lesions due to their properties to support 
axonal growth (12-14).  
Functional improvement has been reported 
after transplantation of lamina propria into 
the whole thoracic spinal (15). 
Transplantation of olfactory mucosa in 
clinical trials has revealed interesting 
results (16). Several studies indicated that 
transplanted OECs could experimentally 
myelinate, in the right environment, the 
demyelinated axons (13, 17). 
Lu et al and Plant et al, reported an 
improvement of locomotor function 
following delayed transplantation of OECs 
into the complete or incomplete thoracic 
spinal lesions (15, 18). 
Preclinical studies exhibited that OEC's 
transplantation following spinal cord 
injury, such as corticospinal tract lesions, 
were associated with myelinating 
regrowing axons and functional 
improvements in the locomotor abilities 
(19). 
Human OECs have been reported to 
remyelinate spinal cord injuries in rodents 
after transplantation, and accordingly in 
clinical trial autologous OECs were 
transplanted in the injured spinal cord of 
paraplegic humans (20). 
OECs are able to stimulate tissue sparing 
and neuroprotection, increase outgrowth of 
both intact and injured axons, activate 
angiogenesis and remyelinte the 
demyelinating axons (21). 
According to the previous reports, other 
advantages of using OECs are as follow: 
first, there is evidence that OEC's 
transplantation reduces the proteoglycans 
expression in the reactive astrocytes after 
photochemical lesions to spinal cord (22, 
23). Second, OEC's reduce sprouting at the 
lesion area but increase the axonal growth 
into the distal part of transected spinal cord 
(24). It is believed that the role of OECs in 
the olfactory system is to direct the newly 
generated axons to their correct position in 
the CNS environment of the olfactory bulb 
(10). Third, it seems the growth factors 
produced by OECs play important roles in 
CNS regeneration. In vitro cultured rats' 
OECs could express NGF, GDNF, BDNF 
and their receptors. NGF and BDNF are 
important factors for survival and regrowth 
of damaged neurons. In addition, NGF, 
BDNF and PLP are the growth factors of 
OECs which are known to support neurite 
outgrowth (25). 
In the other hand, OECs of the olfactory 
mucosa can be obtained by simple biopsy 
through the external nares in all 
individuals without affecting the smell 
sensation. OECs from olfactory mucosa 
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candidate for autologous transplantation to 
avoid graft rejection, in the nervous system 
specialy for spinal cord repair (26, 27). 
In addition, mitotic activity rate and 
migration OECs from the lamia propria of 
olfactory mucosa (OM-OECs) is higher 
than OECs from the OB-OECs (28). 
Therefore, the mentioned advantages of 
OM-OECs prompt us to choose OM-OECs 
for study. So in this research OECs were 
separated from olfactory mucosa of 7 days 
old rats' pups and cultured, followed by 
immunolabeling for p75 and GFAP 
markers of OECs, and then their purity 
were examined by flow-cytometry after 
simultaneous double staining for p75 and 
GFAP markers.  
Materials and methods 
OECs culture: All cultures have been 
performed in the sterile conditions with 
autoclaved all surgery tools. Primary 
cultures of OM-OECs were prepared as 
described previously with slight 
modifications (29). Briefly, 7 days old 
wistar rats' pups were deeply anesthetized 
by ketamine /Xylazine (60/6mg/Kg) and 
the nasal cavity was opened sagittally. 
Care was taken to avoid taking nasal septal 
cartilage. The OM of the rat is easily 
identified by its one-third posterior 
position on the nasal septum and by 
yellowish appearance of the epithelial 
surface (27). Respiratory mucosa was 
carefully removed from the post-anterior 
part of the nasal septum. After several 
times washing in the PBS with and then 
without 1% penicillin/streptomycin 
samples from each rat were digested 
enzymatically in 1 ml of trypsin 1% for 45 
     t 3  C. Trypsinization was stopped 
by  dd  g Dulbecco’s Mod f ed 
E gle’s/H  ’s F12  ed u  
(D.M.E.M/F12, Invitrogen), supplemented 
with 10% Fetal Bovine Serum (F.B.S, 
Invitrogen) and 1% penicillin/streptomycin 
(Invitrogen) (DF-10S). Then the olfactory 
epithelium of OM was removed and 
underneath lamina properia was triturated 
and cut in some small pieces using a 
micropipette, until a homogenous soup 
(cell suspension) was obtained .The 
obtained soup was centrifuged at 1200 rpm 
for 10 minutes, followed by resuspention 
in DF-10S and the centrifugation was 
repeated again. Then, cells were plated in 
25 cm
2
 flasks pre-coated with poly-L-
Lysine (50 mg/ ml, Invitrogen) containing  
5ml of DF-10S  plus 2µM of  forskoline  
mitogenic factor (30, 31) and 1% 
penicillin/streptomycin. The flasks were 
  cub ted  t 3  C, 5% CO2. 
Most of the fibroblasts and astrocytes were 
attached to the flask surface after 24h and 
48 hours respectively, while OECs 
remained unattached (32). Therefore, after 
72h OECs were collected from the 
supernatant and replated onto another flask 
and were left to grow to confluency for 14 
days .The medium was changed daily. 
Immunocytochemistry (ICC) of OECs: 
Some markers used for identification of 
OECs are p75, GFAP and S100 (33-35). 
To determine OECs by p75 and GFAP 
markers in the culture, additional cell 
culturing was performed on cover slips 
pre-coated with poly-L-Lysine (50 mg/ ml, 
Invitrogen) and was processed for 
immunocytochemistry. The simultaneous 
double immunostaining was performed for 
p75/GFAP, and only double positive cells 
in these staining were considered as OECs 
(33-35). The primary antibodies used were 
as follow: anti-p75 (Abcam,rabbit, 1:200) 
and anti-GFAP (Abcam ,mouse,1:200). 
The secondary antibodies used for the 
immunostaining were Alexa flour488 goat 
anti mouse and Alexa flour 568 goat anti 
rabbit (Abcam, 1:1000 for both). 
The procedure briefly is described as 
follows: 5×10
2
 cells were cultured on the 
cover slips pre-coated with poly-L-Lysine 
(50 mg/ ml, Invitrogen) for 72h. Cell 
cultures were primary fixed in fresh 4% 
phosphate-buffered paraformaldehyde for 
2 minutes. Then a secondary fixation was 
carried out in fresh 2% phosphate-buffered 
paraformaldehyde for 10 minutes at 
ambient temperature, followed by fixative 


































    
    














 ]  
Original article                                                               J Bas Res Med Sci 2016; 3(4):12-21 .  
15 
 
for 10 minutes to cells become permeable 
to primary antibodies. Nonspecific binding 
was minimized with goat serum 10% for 
1h followed by incubation with primary 
antibodies overnight at room temperature. 
Secondary antibodies were incubated for 
1h at room temperature in dark. 
Cells were counterstained for 5min by 
DAPI (1µg/ml) in dark. Then the samples 
were washed three times with PB (.1 M, 
PH=7.4) and one time with Diionized 
water and then were mounted with 
glycerol buffer and were observed by 
fluorescent microscope (Olympus AX70). 
It should be noted that all steps after 
secondary antibodies, incubation was 
performed in dark. Between each step, 
cover slips were washed tree times in PB 
(.1M, PH=7.4) for 10 minutes. 
Additionally, negative controls were 
stained in parallel but primary antibodies 
were omitted. Double positive cells for 
p75/GFAP were considered as OECs. 
Purity evaluation of cultured OECs: For 
purity determining of cultured OECs 
Flow-cytometry was carried out. 
Simultaneous double staining for 
p75/GFAP was performed. The primary 
antibodies used for this procedure were 
anti-p75 (Abcam, rabbit, 1:200) and anti-
GFAP (Abcam, mouse, 1:200). 
The secondary antibodies used were as 
follow: Alexa flour488 goat anti mouse 
and Alexa flour 568 goat anti rabbit 
(Abcam, 1:1000 for both).  
The cells were washed with PB (.1 M, 
PH=7.4) and treated with trypsin/EDTA. 
Then, cells were washed with PB and 
double immunolabeled, during 1h at 
ambient temperature, with the anti-
p75/anti-GFAP. At the end of incubation, 
2 ml of PB .1 M (PH=7.4) was added and 
the cells were centrifuged (1200rpm for 10 
min). Cells were incubated with the 
secondary antibodies (1:1000) for 1h in the 
dark. At the end of the incubation, 2 ml of 
PB .1 M (PH=7.4) was added and the cells 
were centrifuged (1200rpm for 10 min). 
Then, cells were resuspended in 1 ml of 
PB (.1 M, PH=7.4). The total number of 
10,000 events was analyzed on a flow-
cytometer (FACS, USA) directly after the 
staining procedure. The experiments were 
triply repeated and the results were 
expressed as mean ± standard deviation 
(SD). 
Statistical analysis 
Statistical analysis was performed using 
MiniTab software (release 11.12, Minitab 
Inc., State College, PA, USA). The 
experiments were all repeated three times 
and the results reported as mean ± standard 
deviation (SD) at a significance level of 
p≤0.05. Differences were considered 
statistically significant when the p value 
was equal or less than 0.05. 
Results  
As Figure 1 indicates the cultured OECs 
demonstrated two different phenotypes 
after attaching to flask surface, including a 
spindle shape Schwann-like and an 
astrocyte-like OECs with flat sheet-like 
morphology In addition, simultaneous 
immunolabeling for p75 and GFAP 
markers of OECs demonstrated OECs 
positivity for both markers at the same 
time (Figure 2).  
Furthermore, the flow-cytometry results  
displayed 87.9±2.4% of cells were p75/ 
GFAP double positive cells, 1.05 ±.4 only 
p75 positive and 5.8±1.5% were single 
positive for GFAP ( Figure 3). The 
experiments for flow-cytometry were 
repeated three times and the results were 
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Figure 1. Phase-contrast images of primarily cultured OECs for 10 days. Both morphology of cultured OECs 
defined as Schwann-like and Astrocyte-like (fibroblast like): A) Schwann-like with a long fusiform bipolar 
morphology, B and C) both types of OECs observed with different magnifications. Astrocyte-like with a flat 
sheet-like morphology and short randomly oriented processes. 
 
 





 are double positive cells for p75 and GFAP markers at the same time. Counterstaining 
(nuclear staining) was performed by DAPI in all samples. 
Discussion  
Cell transplantation is one of the most 
popular strategies for SCI repair. So, the 
main objective of the current research was 
OECs purifying in the primary cultures by 
simple method and determining their 
purity. Hence, OECs were isolated from 
olfactory mucosa (OM) of 7 days old 
wistar rats' pups and were cultured. For 
determining of OECs and their purity 
Immunocytochemistry and Flow-
cytometry were performed respectively. 
Cultured OEC's by our team demonstrated 
two different phenotypes after attaching to 
flask surface which was in accordance 
with other researchers who also reported 
two subpopulations of OEC’s (31, 36). 
Barnet and Riddle exhibited two subtypes 
of OEC's that were purified from the 
olfactory bulb of 7-day old Sprague- 
Dawly rats' pups after 12 days that was in 
agreement with our findings (37). 
Ensheathing cell morphology is 
categorized as flat or process-bearing. Flat 
OEC's (schwann-like) characterized by 
their long fusiform bipolar morphology 
(35). Process-bearing (Astrocyte/or 
fibroblast-like) OEC's are identified  with 
very little cytoplasm and some fine 
randomly oriented processes longer than 
the width of the cell body (35) .Vincent 
and coworkers proposed that the 
morphological plasticity of OEC's is 
related to the culture conditions and is 
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Figure 3. Cell population graph, A) Dot Plot, B) Histogram from flow-cytometry of OECs for p75/GFAP 
markers after second passage of cultured cells. In the Dot plot UR demonstrates cells that were double positive 
for two markers simultaneously, but UL and LR demonstrate cells that were single positive for one marker only. 
Experiment was performed three times (sample1, 2, 3) to confirm  it's reproducibility and results were expressed 
as mean ± SD. Control group (Negative control) was the group in which primary antibodies were omitted and 
were stained in parallel. 
 
Vincent and his research group showed 
that cultured OEC's undergo rapid and 
reversible changes between flat 
morphology in the presence of serum and 
process-bearing morphology in the 
absence of serum (35).  
Purity of OEC's was examined after 
simultaneous double staining for p75/ 
GFAP, by flow-cytometry. The cell 
markers p75 and GFAP were chosen to 
identify OEC's owing to no coexpression 
of these proteins by other cell types from 
the olfactory mucosa. Only cells, 
immunopositive for both markers were 
defined as OEC's (35). Our flow-
cytometry results showed that 87.9±2.4% 
of cells were p75/ GFAP double positive 
cells, 1.05 ±0.4 only p75 positive and 
5.8±1.5% were single positive for GFAP 
only. But p75+/GFAP+ and p75+/S100+ 
or GFAP+/S100+ were olfactory 
ensheathing cells. In the culture procedure 
used in this study, 87.9% of cells were the 
population of p75+/GFAP+ OEC's alone. 
Thus purity of our culture was probably 
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p75 and GFAP positive cells (p75+ and 
GFAP+) in this immunostaining could be 
as p75+/S100+ and GFAP+/S100+ OEC's. 
Hence triple immunolabeling for these 
three markers of OEC' was more efficient 
to complete determining of OEC's purity, 
amounts of astrocytes and other cells 
which could contaminate our culture.  
Schwann cells from the trigeminal nerve 
are considered as bipolar p75-positive and 
GFAP-negative and cells that labeled 
strongly with GFAP but not p75-positive 
(p75-/ GFAP+) are considered as 
astrocyte. Astrocytes are abundant in the 
olfactory nerve layer (ONL) culture 
whereas they are absent in the OM culture 
(35). 
In agreement with our results, there are 
findings of investigators that reported the 
percentage of OM-OEC's after single 
labeling for p75 marker by flow-cytometry 
for 85% (38). 
But these investigators, in another report, 
reported that approximately 10% of OM-
OEC's were p75-positiveby 
immunocytochemistry and flow-cytometry 
(39). 
Another research by Vincent and his 
coworkers  cultured OEC's from both 
olfactory mucosa (OM) and olfactory 
nerve layer (ONL), in unpurified separated 
cultures for 2 days in serum-containing 
Dval-10dS medium  and reported that in 
both cultures, up to 70% of OEC's were 
process-bearing (astrocyte-like) and 30% 
were flat(Schwann-like), and both 
morphologies displayed GFAP staining. In 
this study p75/GFAP –positive cells were 
approximately 14% of total population in 
the OM culture and approximately 6% in 
the olfactory nerve layer (35). Some 
possible explanations that account for this 
discrepancy probably are: the time 
difference (2 days in Vincent study and 14 
days in our study) and method and 
supplement used for OEC's culture as well 
as kind of the technique used for purity 
assessment (imunolabeling in Vincent 
study but flow-cytometry in our study). 
The different experimental procedures 
used by investigators to purify and culture 
OEC's seem to partially contribute the 
varied descriptions of this cell type (35). 
Additionally, in the culture, the proportion 
of each subtype changes with the length of 
culture time (31). 
Conclusion 
Purity of cultured OECs for p75+/GFAP+ 
cells of the culture  was 87.9±2.4%  by 
flow-cytometry and it's percentage may be 
more than this if the p75+/S100+ and 
GFAP+/S100+ cells were immunostained 
and counted. Thus the culture procedure of 
this study seems to be a good protocol for 
OEC's purifying and cell therapy. 
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